Chronic respiratory illnesses affect millions. Learn how PCPs can effectively manage asthma, COPD, and allergies through ...

Lupin partners with SUP to commercialize Tiotropium DPI in China, aiming to improve respiratory health with innovative products.

People with one of more than 20 breathing conditions could be eligible for up to £749 a month from the Department for Work ...

Lupin partners with SUP to commercialize Tiotropium DPI in China for COPD treatment, expanding respiratory care options.

Plenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance ...

Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...

Mumbai: Global pharma major Lupin Limited has signed a supply and license agreement with Sino Universal Pharmaceuticals (SUP) ...

As per the agreement, SUP will obtain regulatory approvals for selling Tiotropium DPI in China, while Lupin will be the ...

Under the terms of the agreement, SUP will be responsible for obtaining the necessary regulatory approvals to sell Tiotropium ...

The following is a summary of “Triple overlap of COPD, severe obesity, and high risk of OSA: insights from an NHANES analysis ...

Eddie Finlan (71) says the choir has lifted his spirits. “I was very ill last year and have lost a lot of weight. I was never ...